Effects of Liraglutide on Cardiovascular Outcomes in Patients With Diabetes With or Without Heart Failure Article

Industry Collaboration International Collaboration

cited authors

  • Marso, Steven P.; Baeres, Florian M. M.; Bain, Stephen C.; Goldman, Bryan; Husain, Mansoor; Nauck, Michael A.; Poulter, Neil R.; Pratley, Richard E.; Thomsen, Anne Bloch; Buse, John B.; LEADER Trial Investigators

authors

Publication Date

  • March 17, 2020

webpage

published in

category

keywords

  • GLP-1 receptor agonist
  • heart failure
  • liraglutide
  • major adverse cardiovascular events
  • mortality
  • type 2 diabetes

start page

  • 1128

end page

  • 1141

volume

  • 75

issue

  • 10